Patent · US Active

Pyrrolomycins and methods of using the same

US10954192B2 · kind B2 · utility

0Cited by

2References

17Claims

0Family size

Assignee

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · US

Inventors

Kenneth Bayles · Omaha, US
Rongshi Li · Omaha, US
Yan Liu · Tangshan City, CN

Key dates

Filing date	Jul 9, 2019
Grant date	Mar 23, 2021
Priority date	—
Expiry date	Jul 9, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D249/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Provided herein are pyrrolomycin derivatives, which can be used to modulate Mcl-1, inhibit proliferation of bacteria and pathogens, as well as to treat infectious diseases and cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.